Lab21 to Develop Aspergillus Assay for Second IVD Company | GenomeWeb

By Ben Butkus

Lab21 said this week that it has entered into an agreement with an undisclosed in vitro diagnostics company to develop, manufacture, and distribute a diagnostic assay to detect Aspergillus species for the partner's real-time PCR platform.

Under the agreement, Lab21 will contribute its molecular diagnostic development resources and intellectual property in the fungal diagnostics area to develop and manufacture the new Aspergillus test as OEM reagents for the partner platform.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: certain genes repressed during memory formation, analysis of genomes from single neurons, and more.

NASA plans to test whether DNA sequencing studies can be conducted in microgravity.

Congress passes a continuing resolution to keep the US federal government funded through mid-December.

The Human Genome Project was launched 25 years ago, and at Nature, Francis Collins, James Watson, and Eric Green look back at the lessons learned.